Relief, Finally? DEA Issues Order Expediting Cannabis Rescheduling to Schedule III

On April 22, 2026, a final order issued by the Acting Attorney General and the Drug Enforcement Administration took effect, fundamentally altering the federal regulatory landscape for marijuana. The order moves FDA-approved drug products containing marijuana and marijuana subject to qualifying state-issued medical marijuana licenses from Schedule I to Schedule III of the Controlled Substances … Continue reading “Relief, Finally? DEA Issues Order Expediting Cannabis Rescheduling to Schedule III”